AU:IPD Stock Latest News
Company AnnouncementsImpedimed Earnings Call: Growth Potential Amid Execution Risk1d ago
Company AnnouncementsImpediMed Releases Investor Presentation on Q1 FY27 Results2d ago
Company AnnouncementsImpedimed Director Boosts Equity Stake Through Fee-For-Shares Arrangement4d ago
Company AnnouncementsImpediMed Director Boosts Indirect Shareholding Through Fee-Paid Share Issue4d ago
Company AnnouncementsImpediMed director boosts stake through fee-for-shares arrangement4d ago
Company AnnouncementsImpediMed Director Increases Stake Through Equity-Based Fee Arrangement4d ago
Company AnnouncementsImpediMed hires cancer survivorship leader to push SOZO toward standard of care5d ago
Company AnnouncementsImpediMed sets date for Q1 FY27 cash flow release and investor webinar6d ago
Company AnnouncementsImpediMed Discloses Director Share Transfer Following Financial Settlement1w ago
Company AnnouncementsImpedimed Seeks ASX Quotation for Additional Ordinary Shares2w ago- Company AnnouncementsImpediMed Director Erik Anderson Significantly Increases Shareholding1M ago
Company AnnouncementsImpediMed Keeps Existing Structure for Attaching and Follow-On Options After ASX Ruling1M ago
- Company AnnouncementsImpediMed grows revenue but posts deeper loss as asset backing erodes2M ago
Company AnnouncementsImpediMed Wins FDA Nod for SOZO Sarcopenia Risk Assessment2M ago- Company AnnouncementsImpediMed flags ASX rule breaches, tightens capital compliance controls2M ago
Company AnnouncementsImpedimed Options Lapse Trims Potential Share Dilution2M ago
Company AnnouncementsImpediMed Releases Investor Presentation on Q4 FY26 Results3M agoCompany AnnouncementsImpediMed lifts Q4 revenue as SOZO footprint and BCRL reimbursement expand3M ago
